Related Experiment Video
Updated: Feb 22, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two
Liana Gheorghe1, Ioan Sporea2, Speranta Iacob3
1Center for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Insights
This guideline provides updated recommendations for treating chronic Hepatitis C virus (HCV) infection in Romania. It covers special patient categories, therapy monitoring, and re-treatment strategies for practitioners.
Area of Science:
- Hepatology
- Infectious Diseases
- Clinical Practice Guidelines
Background:
- Hepatitis C virus (HCV) infection affects approximately 3% of the Romanian population.
- Recent advancements in HCV treatment necessitate updated therapeutic guidelines.
- The Romanian Society of Gastroenterology and Hepatology initiated a re-evaluation of current HCV therapy.
Purpose of the Study:
- To provide updated, consensus-based recommendations for chronic HCV infection management in Romania.
- To address the treatment of specific patient groups, therapy complications, and monitoring.
- To guide practitioners on follow-up and re-treatment strategies for therapy failure.
Main Methods:
- A panel of experts reviewed current literature and major international guidelines.
- Key clinical questions were identified, discussed, and rated by the expert group.
- Consensus was reached on all recommendations presented in the position paper.
Main Results:
- The paper presents the second part of the Society's recommendations for chronic HCV treatment.
- Expert consensus was achieved on managing special patient categories, complications, and monitoring.
- Guidelines for sustained virologic response follow-up and re-treatment were established.
Conclusions:
- This position paper serves as a practical guide for HCV infection assessment and therapy in Romania.
- Recommendations align with international guidelines while considering local real-life conditions.
- The document aims to optimize HCV treatment outcomes for Romanian patients.
Background And Aims:
Hepatitis C virus (HCV) infection is a common condition with endemic prevalence in some areas of the world. In Romania, the mean prevalence is about 3%. New treatments have become available on the market in recent years and new drugs are in the pipeline. A re-evaluation of HCV therapy was considered mandatory. The Romanian Society of Gastroenterology and Hepatology undertook this task for the practitioners of this country.
Methodology:
A group of recognized experts was created who screened the available literature and the major available guidelines. A list of items requiring attention was created and these were discussed and rated. Decisions were taken by consensus.
Recommendations:
We present here the second part of the Society's recommendations for chronic HCV infection treatment. An agreement between experts was reached regarding the therapy of the special categories of patients infected with HCV, complications and monitoring of the therapy, follow-up of the patients who reached sustained virologic response and re-treatment of the patients with therapy failure.
Conclusions:
This Position Paper represents a guide for the assessment and the therapy of HCV infection. The recommendations are in concordance with other guidelines but are applied to real-life conditions in Romania.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:10Retrovirus Life Cycles
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy